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Summary
 
In this study, we investigated the activity of transcription factor NF-
 
k
 
B in macrophages in-
fected with 
 
Yersinia enterocolitica.
 
 Although triggering initially a weak NF-
 
k
 
B signal, 
 
Y. entero-
colitica
 
 inhibited NF-
 
k
 
B activation in murine J774A.1 and peritoneal macrophages within 60 to
90 min. Simultaneously, 
 
Y. enterocolitica
 
 prevented prolonged degradation of the inhibitory pro-
teins I
 
k
 
B-
 
a
 
 and I
 
k
 
B-
 
b
 
 observed by treatment with lipopolysaccharide (LPS) or nonvirulent,
plasmid-cured yersiniae. Analysis of different 
 
Y. enterocolitica
 
 mutants revealed a striking correla-
tion between the abilities of these strains to inhibit NF-
 
k
 
B and to suppress the tumor necrosis
factor 
 
a
 
 (TNF-
 
a
 
) production as well as to trigger macrophage apoptosis. When NF-
 
k
 
B activa-
tion was prevented by the proteasome inhibitor MG-132, nonvirulent yersiniae as well as LPS
became able to trigger J774A.1 cell apoptosis and inhibition of the TNF-
 
a
 
 secretion. 
 
Y. entero-
colitica
 
 also impaired the activity of NF-
 
k
 
B in epithelial HeLa cells. Although neither 
 
Y. entero-
colitica
 
 nor TNF-
 
a
 
 could induce HeLa cell apoptosis alone, TNF-
 
a
 
 provoked apoptosis when
activation of NF-
 
k
 
B was inhibited by 
 
Yersinia
 
 infection or by the proteasome inhibitor MG-
132. Together, these data demonstrate that 
 
Y. enterocolitica
 
 suppresses cellular activation of NF-
 
k
 
B, which inhibits TNF-
 
a
 
 release and triggers apoptosis in macrophages. Our results also sug-
gest that 
 
Yersinia
 
 infection confers susceptibility to programmed cell death to other cell types,
provided that the appropriate death signal is delivered.
 
T
 
he genus 
 
Yersinia
 
 includes three species, which are
pathogenic for rodents and humans. 
 
Y. pestis
 
 is the eti-
ological agent of plague, 
 
Y. pseudotuberculosis
 
 and 
 
Y. entero-
colitica
 
 cause gastrointestinal syndromes, lymphadenitis, and
septicemia (1). Despite of different routes of infection,
these three species share the common capability to resist
the immune response of the host. This enables extracellular
survival and proliferation of the bacteria in the host lym-
phoid tissue (1, 2). The three pathogenic 
 
Yersinia
 
 spp. har-
bor a common 70-kb virulence plasmid (pYV) that en-
codes the 
 
Yersinia
 
 Yop virulon, a sophisticated bacterial
system that mediates delivery of Yops (
 
Yersinia
 
 outer pro-
teins) inside eukaryotic cells by surface-bound bacteria (1,
3, 4). The delivered Yops disrupt key functions of the host
cell (1, 5). At least four Yops, the so-called effector Yops,
YopH, YopE, YopM, and YpkA (YopO in 
 
Y. enterocolitica
 
)
are translocated across the eukaryotic cell plasma membrane
(1). YopE disrupts the actin microfilament structure and
acts synergistically with the protein tyrosine phosphatase
YopH to inhibit phagocytosis and to suppress the oxidative
burst of professional phagocytes (6–10). YpkA/YopO dis-
plays serine/threonine kinase activity and is, like YopH,
supposed to interfere with host cell signaling pathways (11).
Export and translocation of effector Yops is mediated by a
virulence plasmid-encoded protein secretion system and
requires control by YopB, YopD, LcrV, and YopN (1).
Studies in the murine infection model provide evidence
that the 
 
Yersinia
 
 Yop virulon mediates suppression of the
TNF-
 
a
 
 and IFN-
 
g
 
 production in vivo (12). The cytokines
TNF-
 
a
 
 and IFN-
 
g
 
 play a central role in the inflammatory
response to bacterial infection. They are crucial in limit-
ing the severity of 
 
Yersinia
 
 infection (13). Consequently,
inhibition of TNF-
 
a
 
 and IFN-
 
g
 
 synthesis enhances the
ability of 
 
Yersinia
 
 to multiply in the host (12, 13). Previous
studies in our laboratories revealed that 
 
Y. enterocolitica
 
promotes deactivation of mitogen-activated protein kinases
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(MAPKs)
 
1
 
 in cultured macrophages (14). An important role
of MAPK cascades in the regulation of the macrophage
TNF-
 
a
 
 production has been widely documented (15–18),
and our study suggests that 
 
Y. enterocolitica
 
 suppresses the
macrophage TNF-
 
a
 
 production by shortening MAPK ac-
tivities (14). In addition, we and others recently demon-
strated that interaction of 
 
Yersinia
 
 with macrophages culmi-
nates in activation of the intrinsic macrophage cell death
program (19–21). Apoptosis as an innate cell suicide mech-
anism for removing unwanted cells from the multicellular
organism appears to play a role in some infectious diseases
(22). However, the mechanism by which 
 
Yersinia
 
 promotes
macrophage cell death is not clear yet.
In this study, we analyzed the impact of 
 
Y. enterocolitica
 
on activation of transcription factor NF-
 
k
 
B. The active
heterodimer p50/p65 form of NF-
 
k
 
B plays a central role in
immunological processes by controlling expression of a va-
riety of genes involved in inflammatory responses (i.e.,
TNF-
 
a
 
, IL-1, IL-6, IL-8, GM-CSF; reference 23). Fur-
thermore, there is increasing evidence that activation of
NF-
 
k
 
B provides cells with resistance to apoptosis induced
by different stimuli (24–28). NF-
 
k
 
B can be activated in
macrophages by exposure to LPS or inflammatory cyto-
kines such as TNF-
 
a
 
 or IL-1, viral infection, UV radiation,
and by other physiological and nonphysiological agonists
(24–26). In its inactive form, NF-
 
k
 
B is sequestered in the
cytoplasm in a complex with the inhibitory proteins I
 
k
 
B-
 
a
 
or I
 
k
 
B-
 
b
 
 (23, 29). After stimulation by the different induc-
ers, the I
 
k
 
B inhibitors get phosphorylated and degraded
through the ubiquitin–proteasome pathway, thereby re-
leasing NF-
 
k
 
B heterodimer (23, 29). Free NF-
 
k
 
B translo-
cates to the nucleus, where it binds to its target sequences
and activates transcription (23, 29). Duration of NF-
 
k
 
B ac-
tivation has been found to depend on the activating stimuli,
which either degrade I
 
k
 
B-
 
a
 
 and I
 
k
 
B-
 
b
 
 (persistent NF-
 
k
 
B
activation), or only I
 
k
 
B-
 
a
 
 (transient NF-
 
k
 
B activation)
(30). Bacterial LPS induces persistent NF-
 
k
 
B activation by
degrading I
 
k
 
B-
 
a
 
 as well as I
 
k
 
B-
 
b
 
 in responsive cells (30).
Here, we report that 
 
Y. enterocolitica
 
 impairs activation of
NF-
 
k
 
B in murine J774A.1 and peritoneal macrophages and
in human epithelial HeLa cells. Our study implies a direct
link between the prevention of NF-
 
k
 
B activation and apop-
totic cell death as well as TNF-
 
a
 
 suppression in 
 
Yersinia
 
-
infected macrophages. Thus, interference of 
 
Yersinia
 
 with
macrophage NF-kB activation may crucially contribute to
subvert the host immune response and determine the out-
come of Yersinia infection.
Materials and Methods
Bacterial Strains and Growth Conditions. The bacterial strains
used in this study are listed in Table 1. Overnight cultures grown
at 268C were diluted 1:20 in fresh Luria-Bertani broth and grown
for 2 h at 378C as described previously (14, 19). The bacteria
were then washed once and resuspended in PBS at a concentra-
tion of 108 bacteria/ml. The desired bacterial concentration was
adjusted by measuring the optical density at 600 nm and checked
by plating serial dilutions of the samples on agar and counting
CFUs after incubation at 268C for 20 h.
Construction of a Y. enterocolitica yopO/yopP Mutant Strain. Two
PCR primers were deduced from the yopO/yopP homologous ypkA/
yopJ operon in Y. pseudotuberculosis (11) to amplify an internal frag-
ment spanning from bp 223 to 1030. Primer Ypk-Mf GAGTG-
CATGCTGAGGGCTGATGAAAT and Ypk-Mr TATTGCA-
TGCTTATCCTTAGTTTCTATTA harbor additional SphI
restriction sites at their 59 ends (underlined). Y. enterocolitica strain
WA-314, bearing the virulence plasmid pYVO8 (31), was used as
a template to amplify the PCR product of 815 bp. This PCR prod-
uct was purified, cut with SphI, and ligated into the unique SphI
site of the suicide plasmid pGPCAT (32) resulting in pGPC-KM1.
Escherichia coli SM10 was used as host strain for transformation.
pGPC-KM1 was mobilized into strain WA-314 by conjugation
and inserted into pVYO8 by homologous recombination. Transcon-
jugants  harboring the cointegrate (pYVO8::pGPC-KM1) were
selected by chloramphenicol and nalidixic acid resistance. The re-
1Abbreviations used in this paper: DTT, 1,4 dithiothreitol; EMSA, electro-
phoretic mobility shift assay; ERK, extracellular signal–regulated kinase;
JNK, c-Jun NH2-terminal kinase; MAPK, mitogen-activated protein ki-
nase; MEK1, MAPK-ERK kinase 1.
Table 1. Y. enterocolitica Strains Used in this Study
Strain Relevant characteristics Reference
WA-314 Serogroup O8; clinical isolate harboring virulence plasmid pYVO8 31
WA-C Plasmidless derivative of strain WA-314 31
WA-C(pYV-7146) Mutant strain, deficient in YopH secretion; insertional inactivation of sycH,1 0
the gene for the YopH-specific chaperone SycH
WA-C(pYV-515) Mutant strain, deficient in secretion of Yops; insertional inactivation of lcrD,1 0
the gene encoding LcrD, which is essential for Yop secretion
WA-C(pLCR) Strain harboring plasmid pLCR encoding the secretion apparatus 32
of Y. enterocolitica including the genes for YopD, YopB, YopN, and LcrV
WA-C(pLCR, pB8-23) Strain WA-C(pLCR) harboring an additional plasmid encoding the genes 32
for YopH, YopE, and YadA
WA-C(pYV-OP-1) yopO/yopP-negative mutant; insertional inactivation of the yopO/yopP operon This study1071 Ruckdeschel et al.
sulting clone WA-C(pYV-OP-1) was characterized by restriction
enzyme analysis, and inability to produce YopO and YopP was
verified by SDS-PAGE.
Cell Culture and Preparation of Macrophages. The murine mac-
rophage-like cell line J774.A1 and the human epithelial HeLa cell
line were routinely grown in cell growth medium (RPMI 1640
medium supplemented with 10% heat inactivated fetal calf serum
and 5 mM L-glutamine; Life Technologies, Cergy, Pontoise,
France) at 378C and 5% CO2 in a humidified atmosphere. Elic-
ited peritoneal macrophages were obtained from male 8–10-wk-
old Swiss mice 4 d after intraperitoneal inoculation of 1.5 ml of
3% thioglycolate broth. Peritoneal exudate cells were washed and
cultured at 378C in cell growth medium. After 2 h, nonadherent
cells were removed by repeated washing, and remanent macro-
phages were further incubated in cell growth medium at 378C
and 5% CO2.
Stimulation of Cells. Cells were either treated with bacteria,
with 10 mg/ml LPS from E. coli (Sigma Chemical Co., St. Louis,
MO), or with 20 ng/ml human TNF-a (National Institute for
Biological Standards and Control, Hertfordshire, UK) as indi-
cated. Infections were performed at a multiplicity of infection
(MOI) of 50:1 for different periods of time as indicated. After in-
fection, HeLa cells were centrifuged for 5 min at 400 g to facili-
tate contact between bacteria and cells. For incubation times .60
min (J774A.1 cells and peritoneal macrophages) or 90 min (HeLa
cells), bacteria were killed by the addition of gentamicin (100 mg/ml)
after 60 or 90 min of infection, respectively. In some experiments,
cells were pretreated with 10 mM of the proteasome inhibitor Z-Leu-
Leu-leucinal (MG-132; Biomol Research Laboratories, Plymouth
Meeting, MA), the MAPK-ERK kinase 1 (MEK1) inhibitor
PD098059 (50 mM; New England Biolabs, Beverly, MA), or the
p38 (MAPK different from ERK or JNK) inhibitor SB203580 (10
mM; provided by J.C. Lee, SmithKline Beecham, King of Prussia,
PA) for 30 min before stimulation.
Preparation of Nuclear Extracts. Nuclear proteins from cells treated
as indicated were extracted according to a modification of the
procedure described by Thieblemont et al. (33). In brief, cells
were washed with ice-cold PBS and lysed with hypotonic buffer
(5 mM Hepes, pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM
DTT, 0.1 mM PMSF, 5 mg/ml leupeptin, 4 mg/ml aprotinin, 1
mg/ml pepstatin, 2 mg/ml antipain, and 1 mg/ml chymostatin).
The cells were left on ice for 20 min and subsequently centri-
fuged at 1,000 g. The nuclear pellets were resuspended in extrac-
tion buffer (20 mM Hepes, pH 7.9, 25% glycerol, 1 M NaCl, 1.5
mM MgCl2, 0.5 mM EDTA, 0.5 mM 1,4 dithiothreitol (DTT),
0.5 mM PMSF, 2 mg/ml leupeptin, 1.5 mg/ml aprotinin, 0.5 mg/
ml pepstatin, 1 mg/ml antipain, and 0.5 mg/ml chymostatin) and
incubated on ice for 30 min. The nuclear proteins in the superna-
tant were recovered after centrifugation at 16,000 g, quantified by
using a protein assay kit (BioRad Labs, Munich, Germany), and
stored in aliquots at 2808C.
Electrophoretic Mobility Shift Assays. For the electrophoretic
mobility shift assays (EMSAs; reference 33), the NF-kB oligonu-
cleotide probe (59-ACAAGGGACTTTCCGCTGGGGACTT-
TCCAG-39), synthesized by Eurobio (Les Ulis, France), was ra-
diolabeled with g-[32P]ATP using T4 polynucleotide kinase
(Eurogentec, Serraing, Belgium). Nuclear proteins (10 mg) were
preincubated with 5 mg of salmon sperm DNA (GIBCO BRL,
Gaithersburg, MD) on ice for 15 min before addition of 2–5 ng
of the radiolabeled (50,000–100,000 cpm/ng) NF-kB oligonu-
cleotide probe. The DNA-binding reactions were performed in
the presence of 25 mM Hepes, pH 7.9, 0.5 mM EDTA, 0.5 mM
DTT, and 5% glycerol for 30 min at room temperature (final vol-
ume: 20 ml). Competition studies were carried out with a 50-fold
molar excess of unlabeled oligonucleotides added to the reaction
mixtures before addition of radiolabeled oligonucleotides. For su-
pershift assays, 1 ml of rabbit polyclonal IgG directed to the p65
NF-kB subunit (provided by J. Imbert, Institut National de la
Santé et de la Recherche Médicale [INSERM] U119, Marseille,
France; reference 34) was added to the extracts before incubation
with the labeled oligonucleotide probe. After incubation, the re-
action products were analyzed by 6% PAGE using Tris-borate-
EDTA running buffer (45 mM Tris-borate, pH 8.0, 10 mM
EDTA). The gels were dried and analyzed with a PhosphorIm-
ager (Molecular Dynamics, Bondoufle, France).
Western Immunoblot Assays. Cytoplasmic extracts were pre-
pared from 106 cells, treated, as indicated, by lysis in buffer con-
taining 10 mM Tris, pH 8.0, 60 mM KCl, 1 mM EDTA, 0.5%
Nonidet P-40, 1 mM DTT, 1 mM PMSF, 1 mM benzamidin, 20
mM b-glycerophosphate, 5 mM p-nitrophenyl phosphate, and
0.1 mM Na3VO4. Proteins were separated by 10% SDS-PAGE,
electrotransferred to polyvinylidene difluoride membrane, and
blocked with 3% BSA. Immunostaining for IkB-a and IkB-b
were performed with polyclonal rabbit anti–IkB-a and anti–IkB-b
antibodies (Santa Cruz Biotechnology, Santa Cruz, CA). Immu-
noreactive bands were visualized by incubation with donkey
anti–rabbit antibodies conjugated to horseradish peroxidase (Am-
ersham Corp., Arlington Heights, IL) using enhanced chemilu-
minescence reagents (New England Nuclear Life Science, Bos-
ton, MA).
Assessment of Apoptosis by Fluorescence Microscopy. Apoptotic cells
were detected and quantified by an assay based on the detection
of phosphatidylserine exposed on the outer leaflet of apoptotic
cells as described previously (19). Cells treated as indicated were
stained with FITC-conjugated annexin V (Annexin-V-Fluos; Boeh-
ringer  Mannheim GmbH, Mannheim, Germany), which binds
with high affinity to membrane-exposed phosphatidylserine. The
simultaneous application of the DNA stain propidium iodide
(Sigma Chemical Co.) allowed discrimination of apoptotic from
necrotic cells. The percentages of apoptotic cells were determined
by counting a minimum of 100 cells/sample in a fluorescence mi-
croscope (DM IRB; Leica, Wetzlar, Germany). Results are ex-
pressed as mean percentages of apoptotic cells 6 SD from three
independent experiments.
Quantitation of TNF-a Secretion. For TNF-a quantitation,
J774A.1 cells and peritoneal macrophages were dispatched in
plastic culture plates (5 3 105/sample) and treated as indicated.
The cell culture supernatants were removed after a final 150-min
incubation, and the TNF-a cytokine levels in the supernatants
were evaluated by a cytotoxic assay performed with the TNF-a–
sensitive fibroblast cell line L929 as described previously (14). Ex-
periments were performed in quadruplicate. Results are expressed
as mean percentages of picograms of TNF-a per milliliter 6 SD
from one representative experiment out of three performed.
Results
Y. enterocolitica Inhibits Nuclear Translocation of NF-kB in
J774A.1 Macrophages. To evaluate a role of NF-kB in the
macrophage response to Y. enterocolitica infection, we ana-
lyzed nuclear translocation of NF-kB in Y. enterocolitica–
infected J774A.1 macrophages by EMSA. J774A.1 cells
were either infected with virulence plasmid–cured (WA-C)
or with virulence plasmid–harboring wild-type (WA-314)
yersiniae, or treated with LPS from E. coli. At different1072 Y. enterocolitica Impairs Activation of Transcription Factor NF-kB
time points after challenge, nuclear protein extracts were
assayed for NF-kB DNA-binding activities using a radiola-
beled NF-kB–specific probe (33). As shown in Fig. 1 A,
strong radioactive DNA binding to nuclear proteins was
observed after 30 min when cells were treated with LPS or
virulence plasmid–cured Y. enterocolitica. Infection with
wild-type yersiniae for 30 min induced formation of a pro-
tein–DNA complex migrating at the same mobility, but
the DNA-binding activity of this complex was greatly re-
duced as compared to virulence plasmid–cured yersiniae or
to LPS. To examine the specificity of the DNA-binding
capability of the complexes generated by virulence plas-
mid–cured and –harboring yersiniae after 30 min, a 50-fold
molar excess of unlabeled NF-kB oligonucleotides was
added for competition (Fig. 1 B). As expected, the unla-
beled oligonucleotides prevented formation of radiolabeled
protein–DNA complexes. Incubation with an antibody di-
rected to the p65 NF-kB subunit resulted in supershift of
these complexes, confirming their identities as transcription
factor NF-kB (Fig. 1 B). Translocation of NF-kB in re-
sponse to treatment with virulence plasmid–cured strain
WA-C or with LPS was enhanced after 60 min and per-
sisted at least up to 90 min (Fig. 1 A). In contrast, nuclear
extracts from cells infected for 60 and 90 min with wild-
type Y. enterocolitica did not give rise to complex formation
anymore, indicating that the low nuclear translocation of
NF-kB induced by wild-type yersiniae within 30 min is
only short living and already completely abolished after 60
min. These data demonstrate that wild-type Y. enterocolitica
suppresses translocation of NF-kB to the nucleus and, thus,
prevents prolonged NF-kB activation. In addition, infec-
tion of J774A.1 cells with wild-type Y. enterocolitica for 60
min inhibited activation of NF-kB in response to subse-
quent challenge with LPS from E. coli (data not shown), in-
dicating that Yersinia infection actively suppresses the NF-
kB signal induced by LPS.
Y. enterocolitica Inhibits Prolonged Degradation of IkB-a and
IkB-b. We examined the changes in cytoplasmic IkB-a
(37 kD) and IkB-b (46 kD) protein levels of J774A.1 cells
to determine whether degradation of these inhibitory pro-
teins correlates with the respective level of NF-kB activa-
tion. Immunoblotting analysis revealed that virulence plas-
mid–harboring yersiniae (WA-314) as well as virulence
plasmid–cured yersiniae (WA-C) and LPS rapidly induced
phosphorylation and proteolysis of IkB-a within 10–30
min (Fig. 2). Phosphorylation of IkB-a resulted in an up-
ward shift of IkB-a in the SDS-PAGE because of slower
electrophoretical mobility (35). IkB-a phosphorylation and
degradation occured even faster in case of infection with
the wild-type strain WA-314 (Fig. 2, lane 4) as compared
to strain WA-C (Fig. 2, lane 3). This effect may be attrib-
uted to the presence of the virulence plasmid–encoded cell
adhesin YadA, since a yadA-negative mutant (36) revealed
a kinetic of IkB-a degradation similar to virulence plas-
mid–cured yersiniae (data not shown). This is also in line
with a faster increase of the oxidative burst of polymorpho-
nuclear leukocytes infected with YadA-bearing yersiniae as
compared to leukocytes treated with yersiniae lacking
YadA (10). Fig. 2 shows that, after 45 min, newly synthe-
sized IkB-a accumulated and increasing amounts of IkB-a
reappeared in the immunoblot. However, only J774A.1
macrophages infected with wild-type strain WA-314 com-
pletely restored their IkB-a level within 60 min and no
phosphorylated forms of IkB-a could be detected any-
more. In contrast, IkB-a in cells treated with LPS or with
strain WA-C remained phosphorylated and degraded to a
remarkable degree throughout the time investigated. The
Figure 1. Y. enterocolitica im-
pairs activation of NF-kB in
J774A.1 macrophages. (A) Ki-
netics of NF-kB DNA-binding
activity in J774A.1 macrophages
treated with Y. enterocolitica and
LPS as detected by EMSA.
J774A.1 cells were untreated
(lane  1) or stimulated with LPS
(lane 2), with the virulence plas-
mid–cured Yersinia strain WA-C
(lane 3) or the virulent wild-type
strain WA-314 (lane 4). The
NF-kB activities were deter-
mined after 30, 60, and 90 min
of stimulation. (B) Investigation
of the identity of NF-kB by su-
pershift assay with an antibody
directed against the p65 NF-kB
subunit (p65 Ab), and by com-
petition with a 50-fold molar ex-
cess of the unlabeled oligonucle-
otide (cold probe). Experiments
were performed with the NF-kB
complexes obtained by infections
with strain WA-C and WA-314
after 30 min.
Figure 2. Y. enterocolitica inhibits prolonged degradation of IkB-a and
IkB-b in J774A.1 macrophages. The kinetics of degradation of IkB-a
and IkB-b was determined in untreated J774A.1 macrophages (lane 1)
and in macrophages stimulated with LPS (lane 2), with the virulence plas-
mid–cured Yersinia strain WA-C (lane 3), and with the virulent wild-type
strain WA-314 (lane 4). The cytoplasmic lysates of stimulated J774A.1
cells were prepared at the time points indicated, subjected to SDS-PAGE,
and immunoblotted with polyclonal anti–IkB-a and anti–IkB-b antibod-
ies, respectively.1073 Ruckdeschel et al.
results obtained for IkB-b were similar to those obtained
for IkB-a, although degradation of IkB-b in response to
treatment with LPS and both Yersinia strains was not as dra-
matic as for IkB-a and occurred later (30–45 min). How-
ever, also in the case of IkB-b, infection with strain WA-
314 caused complete restoration of the cytoplasmic pool of
the inhibitory protein at time points when degradation of
IkB-b due to treatment with LPS or virulence plasmid–
cured yersiniae was still obvious (60–120 min). Thus, the
correlation between the lack of persistent IkB-a/IkB-b
degradation and the inhibition of NF-kB translocation sug-
gests that Y. enterocolitica suppresses NF-kB activation by
preventing prolonged proteolysis of the inhibitory proteins.
Y. enterocolitica–mediated Inhibition of NF-kB Activation
Correlates with J774A.1 Cell Apoptosis and Suppression of
TNF-a Production. Since NF-kB was reported to play a
central role in the regulation of apoptotic cell death and of
cytokine secretion (23–29), we wondered whether the in-
hibition of NF-kB translocation is related to Yersinia-induced
apoptosis and TNF-a suppression. We compared nuclear
translocation of active NF-kB in response to infection with
different Y. enterocolitica mutants (Fig. 3 A) with the capa-
bilities of these strains to trigger J774A.1 cell apoptosis (Fig.
3 B) and to block TNF-a production (Fig. 3 C). TNF-a
secretion in the culture supernatant was determined after
150 min, a time point when onset of J774A.1 cell apoptosis
due to infection with wild-type yersiniae starts to be de-
tectable (19). Previously, we demonstrated that apoptosis
and TNF-a inhibition induced by Y. enterocolitica depend
on a functional Yop secretion system, but occur indepen-
dently of the presence of the tyrosine phosphatase YopH
(14, 19). In line with these results, we now found that the
YopH secretion negative strain WA-C(pYV-7146) (sycH
mutant) prevented the translocation of NF-kB (Fig. 3, lane
4). On the contrary, strain WA-C(pYV-515), which is af-
fected in the secretion of all Yops (lcrD mutant), exhibited a
strong NF-kB–binding activity (Fig. 3, lane 6) similar to
strain WA-C (Fig. 3, lane 2). These results show that also
for the inhibition of NF-kB, a functional Yop secretion
system is required, but YopH appears to be dispensable.
Furthermore, we analyzed two Yersinia strains expressing only
a restricted repertoire of yop genes. Strain WA-C(pLCR)
secretes the translocator/regulator proteins YopD, YopB,
YopN, and LcrV. The second strain, referred to as WA-
C(pLCR, pB8-23), additionally secretes YopH and YopE.
These two Yops confer resistance to phagocytosis and sup-
pression of the J774A.1 cell oxidative burst to Y. enterocolit-
ica (14). Nevertheless, neither strain was efficiently inhibit-
ing the translocation of NF-kB, nor promoting apoptosis or
TNF-a suppression. Fig. 3 also displays the results obtained
with a Y. enterocolitica mutant selectively affected in the ex-
pression of the serine/threonine kinase gene yopO and the
cotranscribed yopP. This mutant was remarkably impaired
in its ability to induce apoptosis (52 6 15% apoptotic cells)
and to inhibit the TNF-a production (0.65 6 0.04 ng
TNF-a/ml), as compared to the virulent wild-type strain
(90 6 4% apoptotic cells, 0.14 6 0.05 ng TNF-a/ml). In-
terestingly, this strain was also not as efficient as the wild-
type strain to inhibit the translocation of NF-kB (intensity
of NF-kB DNA-binding activity of 12 for the yopO/yopP
mutant, and of 5 for the wild-type strain; Fig. 3). Thus, our
data point out a close correlation between the capability of
Y. enterocolitica to prevent activation of NF-kB, to trigger
apoptosis, and to suppress the TNF-a production in J774A.1
Figure 3. Correlation be-
tween inhibition of the NF-kB
response, and apoptosis and
TNF-a suppression in J774A.1
cells infected with different Y.
enterocolitica mutants. (A) J774A.1
cell NF-kB activities. (B) Quan-
titation of J774A.1 cell apoptosis.
(C) Quantitation of J774A.1 cell
TNF-a production. J774A.1
cells were either untreated (lane
1), or infected with the virulence
plasmid–cured strain WA-C
(lane  2), the virulent wild-type
strain WA-314 (lane 3), the
YopH secretion-negative strain
WA-C(pYV-7146) (lane 4), the
yopO/yopP mutant WA-C(pYV-
OP-1) (lane 5), the Yop secre-
tion-negative strain WA-C(pYV-
515) (lane 6), strain WA-C(pLCR) secreting YopD, YopB, YopN, and
LcrV (lane 7), and strain WA-C(pLCR, pB8-23) secreting YopD, YopB,
YopN, LcrV, YopH, and YopE (lane 8). (A) The NF-kB activities of
J774A.1 cells were determined 60 min after infection by EMSA and
quantified with a PhosphorImager. The radioactive intensities of the NF-kB
DNA-binding activities are given below the respective NF-kB signal.
This figure shows one experiment representative for three performed.
Only sections of the autoradiogram containing the protein–DNA com-
plexes are shown. (B) Apoptosis of J774A.1 cells was assayed 4 h after on-
set of infection by staining the cells with fluorescein-conjugated annexin
V and propidium iodide, and counting apoptotic cells in a fluorescence
microscope. (C) The TNF-a activities in the cell culture supernatants (di-
lution 1:40) were measured 150 min after the onset of infection, using a
cytotoxic assay performed with the TNF-a–sensitive fibroblast cell line
L929.
Figure 4. Y. enterocolitica impairs activation of NF-kB in murine perito-
neal macrophages. (A) Kinetics of NF-kB DNA-binding activity. (B)
Kinetics of degradation of IkB-a and IkB-b. Murine peritoneal mac-
rophages were untreated (lane 1) or stimulated with LPS (lane 2), with
the virulence plasmid–cured Yersinia strain WA-C (lane 3) or the virulent
wild-type strain WA-314 (lane 4). After 30, 60, and 90 min, (A) the NF-
kB activities were determined by EMSA and (B) the IkB-a and IkB-b
protein levels were determined in cytoplasmic lysates subjected to SDS-
PAGE and immunoblotted with polyclonal anti–IkB-a and anti–IkB-b
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macrophages. The caspase inhibitor ZVAD.fmk, which ef-
ficiently blocks execution of the Yersinia-induced apoptotic
program (19), did not interfere with TNF-a suppression
mediated by Yersinia (data not shown), indicating that TNF-a
suppression is not a result of the apoptotic process.
Murine Peritoneal Macrophages Respond to Y. enterocolitica In-
fection as J774A.1 Cells. To determine whether Y. entero-
colitica interferes with the activation of NF-kB also in pri-
mary macrophages, we investigated the effects of Yersinia
infection on murine peritoneal macrophages. EMSAs re-
vealed that virulent wild-type yersiniae impaired nuclear
translocation of NF-kB in peritoneal macrophages within
90 min (Fig. 4 A). In contrast, virulence plasmid–cured
yersiniae induced an increasing NF-kB response, similar to
J774A.1 cells. Supershift experiments with the anti-p65 an-
tibody identified the detected protein–DNA complexes as
NF-kB (data not shown). Analyzing the IkB-a and IkB-b
protein levels, we found that IkB-a as well as IkB-b were
efficiently degraded upon infection with both Yersinia
strains (Fig. 4 B). However, as in J774A.1 cells, substantial
amounts of IkB-a and IkB-b were regenerated within 60–
90 min, specifically in macrophages infected with the wild-
type strain. Additionally, apoptosis and inhibition of the
TNF-a production were found only in peritoneal mac-
rophages treated with wild-type Y. enterocolitica, but not
with the virulence plasmid–cured strain (Table 2). Thus,
the effects observed on J774A.1 cells appear to hold true also
for primary peritoneal macrophages, validating J774A.1
cells as an appropriate infection model for analyzing Yer-
sinia–macrophage interaction.
Prevention of NF-kB Activation by Proteasome Inhibitor MG-
132 Triggers Apoptosis in J774A.1 Cells Treated with Virulence
Plasmid–cured Yersiniae or LPS. To confirm a possible rela-
tion between the blockage of NF-kB activation and the
onset of apoptosis, we sought a compound inhibiting effi-
ciently and selectively the translocation of NF-kB. Since
NF-kB translocation depends on the protease activity in
the proteasome, which degrades IkBs (23, 29, 37), we used
the peptide Z-Leu-Leu-leucinal (MG-132), which specifi-
cally inhibits the proteasome pathway (37, 38). Pretreat-
ment of J774A.1 cells with this compound substantially in-
hibited IkB-a degradation (data not shown) and NF-kB
activation due to infection with virulence plasmid–cured
yersiniae (Fig. 5, lane 3). Interestingly, after 4 h of incuba-
tion, .90% of the cells pretreated with MG-132 and in-
fected with virulence plasmid–cured yersiniae underwent
apoptosis (Table 3). The same held true for J774A.1 cells
stimulated with LPS after pretreatment with MG-132.
These results once again suggest a direct link between the
level of NF-kB activation and the readiness of J774A.1 cells
to undergo apoptotic cell death upon stimulation. When
we analyzed the impact of MG-132 on the TNF-a re-
sponse, we found that the TNF-a production induced by
virulence plasmid–cured yersiniae and by LPS was com-
pletely abolished by pretreatment with MG-132 (Table 3).
These data imply a key role of NF-kB activity not only in
the prevention of apoptosis, but also in the regulation of
the TNF-a production.
Table 2. Wild-type Y. enterocoliticia Inhibits the TNF-a 
Production and Triggers Apoptosis in Murine Peritoneal Macrophages
Stimulation TNF-a production* Percent apoptotic cells‡
pg/ml
None 5 6 1 3.5 6 2
LPS 88 6 9N D
WA-C 66  6 4 4.5 6 2
WA-314 11 6 3 81 6 8
*The TNF-a activity in the cell culture supernatant (dilution 1:25) was
measured 150 min after the onset of stimulation using a cytotoxic assay
performed with the TNF-a–sensitive fibroblast cell line L929.
‡Apoptosis was assayed 4 h after onset of stimulation by staining the
cells with fluorescein-conjugated annexin V and propidium iodide, and
counting apoptotic cells in a fluorescence microscope.
Figure 5. The NF-kB response
induced by virulence plasmid–cured
Y. enterocolitica (WA-C) in J774A.1
cells is reduced by pretreatment with
the proteasome inhibitor MG-132,
but not by pretreatment with
SB203580 and PD098059. J774A.1
cells were untreated (lanes 1–2), pre-
treated for 30 min with either 10 mM
of the proteasome inhibitor MG-132
(lane 3), or a combination of the p38
inhibitor SB203580 (10 mM) and the MEK1 inhibitor PD098059 (50
mM; lane 4). Thereafter, cells were infected with the virulence plasmid–
cured Yersinia strain WA-C (lanes 2–4). After 45 min, NF-kB activities
were analyzed by EMSA.
Table 3. Pretreatment with the Proteasome Inhibitor MG-132 
Triggers Apoptosis and Suppresses the TNF-a Production in J774A.1 
Macrophages Stimulated by LPS or Virulence Plasmid–cured Y. 
enterocolitica (WA-C)
Stimulation*
Percent apoptotic cells‡ TNF-a production§
2MG-132 1MG-132 2MG-132 1MG-132
None 6 6 37  6  2 31 6 5 36 6 10
LPS 8 6 4 96 6 3 1,725 6 96 61 6 42
WA-C 9 6 4 94 6 4 1,630 6 68 17 6 5
WA-314 90 6 4 95 6 6 144 6 53 21 6 6
*J774A.1 cells remained unstimulated or were treated with either LPS,
virulence plasmid–cured yersiniae (WA-C), or wild-type yersiniae
(WA-314) under conditions with or without pretreatment with the
proteasome inhibitor MG-132 (10 mM).
‡Apoptosis was assayed 4 h after onset of stimulation by staining the
cells with fluorescein-conjugated annexin V and propidium iodide, and
counting apoptotic cells in a fluorescence microscope.
§The TNF-a activity in the cell culture supernatant (dilution 1:40) was
measured 150 min after the onset of stimulation, using a cytotoxic assay
performed with the TNF-a–sensitive fibroblast cell line L929.1075 Ruckdeschel et al.
Y. enterocolitica-mediated Inhibition of NF-kB Promotes Apop-
tosis of HeLa Cells in Response to TNF-a. In a previous
study, we demonstrated that Y. enterocolitica infection leads
to apoptosis selectively in macrophages, but not in epithe-
lial HeLa cells (19). To reevaluate a possible role of NF-kB
in Yersinia-mediated apoptosis, we studied whether NF-kB
activation was also affected in Y. enterocolitica–infected HeLa
cells. Fig. 6 shows that the virulence plasmid–cured strain
WA-C (lane 6) induced substantial NF-kB–binding activ-
ity, but not as strong as treatment of HeLa cells with TNF-a
(lane 4). Supershift assays with the anti-p65 subunit anti-
body identified the detected nuclear complexes as NF-kB
(Fig. 6, lanes 3, 5, and 7). In contrast, the virulent wild-
type strain WA-314 (Fig. 6, lane 8) prevented nuclear
translocation of NF-kB. However, strain WA-314 did not
induce HeLa cell apoptosis (Table 4). When we treated
HeLa cells either with strain WA-C or WA-314, and re-
stimulated thereafter with TNF-a, strain WA-314 exclu-
sively caused a marked decrease of the resulting NF-kB
signal (compare in Fig. 6 lane 1 with lanes 2 and 4). Strik-
ingly, this mode of treatment led to apoptotic cell death of
62 6 15% of the HeLa cell population after 6 h (Table 4).
Similarly, pretreatment of HeLa cells with the proteasome
inhibitor MG-132 and subsequent stimulation with TNF-a
strongly induced apoptosis, but not the addition of MG-
132 alone. These results support previous studies that dem-
onstrated that the fate of epithelial HeLa cells upon treat-
ment with TNF-a depends on the ability of NF-kB to be
activated (28, 39). Y. enterocolitica, by inhibiting the activa-
tion of NF-kB, promotes apoptosis of HeLa cells in re-
sponse to TNF-a.
Inhibitors of p38 MAPK (SB203580) and MAPK-ERK-
kinase 1 (PD098059) Do Not Interfere with Yersinia-mediated
Apoptosis, but Cumulatively Block the TNF-a Production Induced
by Virulence Plasmid–cured Yersiniae. In a previous study,
we found that Y. enterocolitica initially stimulates and subse-
quently deactivates the macrophage MAPKs extracellular
signal–regulated kinase (ERK)1/2, p38, and c-Jun NH2-
terminal kinase (JNK) (14). There is increasing evidence
that MAPK cascades serve to regulate cell proliferation and
cell death (40). To verify involvement of MAPKs in Yersinia-
induced apoptosis of J774A.1 cells, we analyzed the effects of
two specific inhibitors of MAPK pathways. The compound
SB203580  specifically inhibits p38/CSBP kinase activities
(41), whereas PD098059 selectively blocks activation of the
ERK kinase MEK1, which in turn prevents activation of
ERK1/2 (42). There is no drug available yet to selectively
inhibit the JNK pathway. J774A.1 cells were pretreated
with SB203580 and PD098059, and thereafter challenged
with yersiniae. Our experiments revealed that neither com-
pound, alone or in combination, blocked J774A.1 cell apop-
tosis induced by wild-type yersiniae; in each case, 85–95%
of cells became apoptotic after 4 h of incubation. Thus,
neither the p38 nor the ERK1/2 MAPK pathways seem to
be crucially engaged in Yersinia-mediated apoptosis. In ad-
dition, we analyzed the impact of SB203580 and PD098059
on the J774A.1 cell TNF-a production. Table 5 shows that
both compounds substantially inhibited the TNF-a release
of J774A.1 cells in response to infection with virulence
plasmid–cured yersiniae. These effects seem to be cumula-
tive, since addition of the two compounds together blocked
the TNF-a production completely. However, under the
same experimental conditions, neither compound prevented
NF-kB activation due to infection with strain WA-C (Fig.
5, lane 4), which demonstrates that these inhibitors do not
exert their effects on TNF-a production via the NF-kB
signaling pathway. These results indicate that not only NF-
kB, but also the p38 and ERK1/2 MAPK pathways, are
important regulators of the J774A.1 cell TNF-a produc-
tion in response to bacterial infection.
Figure 6. Y. enterocolitica impairs activation of NF-kB in epithelial
HeLa cells. Treatment of epithelial HeLa cells was performed in two
steps. During the first step, the HeLa cells were untreated (lanes 3, 4, and
9) or infected with either virulence plasmid–cured yersiniae (lanes 2, 5, and
6), or wild-type yersiniae (lanes 1, 7, and 8) for 90 min. Thereafter, half of
the samples were challenged with 20 mg/ml human TNF-a (lanes 1–4)
for 30 min. Nuclear extracts were prepared after the first incubation step
(lanes 5–9) or after additional TNF-a treatment (lanes 1–4), and analyzed
for NF-kB DNA-binding activity by EMSA. Supershift assays with an an-
tibody directed against the p65 NF-kB subunit identified the detected
complexes as NF-kB (lanes 3, 5, and 6).
Table 4. TNF-a Triggers Apoptosis of Epithelial HeLa Cells after 
Pretreatment with Wild-type Y. enterocolitica or the Proteasome 
Inhibitor MG-132
Pretreatment*
Percent apoptotic cells‡
2TNF-a1 TNF-a
None 10 6 69  6  6
WA-C 11 6 27  6  6
WA-314 13 6 4 62 6 15
MG-132 11 6 3 57 6 12
*HeLa cells were either not pretreated, or pretreated for 90 min with
virulence plasmid–cured yersiniae (WA-C), with wild-type yersiniae
(WA-314), or with the proteasome inhibitor MG-132 (10 mM). Thereaf-
ter, half of the samples were challenged with human TNF-a (20 mg/ml).
‡Apoptosis was assayed 6 h after onset of stimulation with TNF-a by
staining the cells with fluorescein-conjugated annexin V and propidium
iodide, and counting apoptotic cells in a fluorescence microscope.1076 Y. enterocolitica Impairs Activation of Transcription Factor NF-kB
Discussion
Pathogenic Yersinia spp. counteract host defense mecha-
nisms by interfering with eukaryotic signal transduction
pathways. In this study, we investigated the impact of Y.
enterocolitica on nuclear translocation of NF-kB, which is a
critical regulator of cytokine expression (23), but also plays
an intriguing role in promoting cell survival (24–28). Our
present data show that Y. enterocolitica strongly impairs acti-
vation of NF-kB in eukaryotic cells. In murine J774A.1
and peritoneal macrophages, wild-type Y. enterocolitica ini-
tially induced a weak NF-kB signal. This signal was com-
pletely abolished after 60 min in J774A.1 macrophages and
almost completely inhibited after 90 min in peritoneal
macrophages, respectively. In contrast, virulence plasmid–
cured yersiniae and LPS promoted persistent NF-kB acti-
vation for at least 90 min. Analysis of the cytoplasmic levels
of the inhibitory proteins IkB-a and IkB-b showed that
infection with wild-type yersiniae caused an initial degra-
dation of IkB-a and IkB-b similar to nonvirulent yersiniae
and LPS. After 60–90 min, however, when NF-kB activity
was inhibited, the cytoplasmic pools of IkB-a and IkB-b
were already completely restored. On the contrary, cells
treated with virulence plasmid–cured yersiniae or with LPS
exhibited a substantial degree of phosphorylation and deg-
radation of IkB-a and IkB-b throughout the time investi-
gated. These results suggest that Y. enterocolitica impairs acti-
vation of NF-kB by preventing prolonged phosphorylation
and degradation of IkB-a and IkB-b inhibitory proteins.
The fact that the suppression of the NF-kB activity oc-
cured after only 60–90 min of infection can be explained
by a delay necessary for Yersinia to exert its effects on the
host cell after host cell contact (1).
To substantiate a possible relation between NF-kB inhi-
bition and induction of apoptosis and blockage of TNF-a
production, we checked a set of genetically designed Y. en-
terocolitica mutants for these activities in J774A.1 cells. In-
deed, we found a striking correlation between the abilities
of these strains to inhibit activation of NF-kB, to promote
apoptosis, and to suppress TNF-a production. The strains
capable of inhibiting translocation of NF-kB also efficiently
blocked TNF-a secretion and strongly induced apoptosis.
Conversely, the strains that elicited a strong NF-kB signal
were not able to trigger apoptosis, but generated a marked
TNF-a response. The experiments on these strains showed
that inhibition of NF-kB is distinct from the effects medi-
ated by YopH and YopE, but depends on a functional Yop
secretion system. This implies that indeed one or several se-
creted virulence factors are involved. Recently, the YopP
protein of Y. enterocolitica (YopJ in Y. pseudotuberculosis) was
reported to play a role in the promotion of macrophage ap-
optosis (20, 21). In this study, we analyzed a Y. enterocolitica
mutant affected in expression of the serine/threonine ki-
nase gene yopO and the cotranscribed yopP. Indeed, this
yopO/yopP double mutant was markedly impaired in its
ability to induce apoptosis. Simultaneously, this mutant was
not as efficient as the wild-type strain to block the secretion
of TNF-a. And, most interestingly, the translocation of
NF-kB was also not as efficiently inhibited. Thus, our data
suggest a direct link between activation of NF-kB and cell
survival/TNF-a production, or, conversely, inhibition of
NF-kB and subsequent cell death/TNF-a suppression in
Yersinia-infected macrophages. This coherence was further
confirmed by the finding that inhibition of NF-kB activa-
tion by compound MG-132, which selectively blocks the
proteasome pathway, triggered apoptosis and TNF-a sup-
pression in J774A.1 cells treated either with LPS or with
nonvirulent yersiniae. These results suggest a dual function
of NF-kB in macrophages infected with nonvirulent yer-
siniae, which is prevention of cell death on the one hand,
and induction of TNF-a production on the other. Wild-
type yersiniae, by counteracting the activation of NF-kB,
impair cell survival and suppress the macrophage TNF-a
production.
The situation in epithelial HeLa cells appears different.
Our previous work showed that HeLa cells do not undergo
apoptotic cell death upon Yersinia infection, in contrast to
macrophages (19). Nevertheless, Yersinia-infected HeLa
cells are severely affected by the actin depolymerizing ac-
tivity of YopE (19). This indicates that Yersinia also exerts
its effects on HeLa cells, but the response of HeLa cells ap-
parently differs from that of macrophages. Our study dem-
onstrated that wild-type Y. enterocolitica also blocked activa-
tion of NF-kB in HeLa cells without triggering apoptosis.
However, when HeLa cells were pretreated with wild-type
yersiniae or with the proteasome inhibitor MG-132, sub-
sequent stimulation with the cytokine TNF-a strongly
promoted HeLa cell apoptosis. In line with the fact that the
activity of NF-kB determines the fate of TNF-a–treated
HeLa cells (28, 39), infection with virulent yersiniae sub-
stantially suppressed the NF-kB response induced by TNF-a.
This signals the cell to undergo apoptosis.
An essential role of NF-kB in preventing cell death has
Table 5. Inhibitors of p38 (SB203580) and MEK1 
(PD098059) Cumulatively Inhibit the TNF-a Production of 
J774A.1 Macrophages Stimulated with Virulence Plasmid–cured Y. 
enterocolitica (WA-C).
Pretreatment*
TNF-a production‡
No bacteria WA-C
Nothing 37 6 4 1,625 6 126
SB203580 59 6 16 752 6 121
PD098059 47 6 10 680 6 150
SB203580 1 PD098059 45 6 8 49 6 5
*J774A.1 cells were either not pretreated or pretreated for 30 min with
the compounds SB203580 (10 mM), PD098059 (50 mM), or the two
compounds together. Thereafter, half of the samples were challenged
by the addition of virulence plasmid–cured yersiniae (WA-C).
‡The TNF-a activity in the cell culture supernatant (dilution 1:120)
was measured 4 h after the onset of infection with strain WA-C, using a
cytotoxic assay performed with the TNF-a–sensitive fibroblast cell line
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been demonstrated for different stimuli, such as TNF-a,
ionizing radiation, or the genotoxic agent daunorubicin
(24–26). Activation of NF-kB appears to provide protec-
tion against apoptotic killing induced by these stimuli (24–
26). TNF-a, which is the best studied agonist of this
group, simultaneously activates cytotoxic and death-pre-
venting pathways. The balance between these two path-
ways determines the fate of the cell. The pathways that pre-
vent cell death depend on protein synthesis, but not the
cytotoxic pathways (43). NF-kB functions to transcription-
ally upregulate a gene or group of genes encoding proteins
that mediate cell survival, such as proteins of the IAP (in-
hibitor of apoptosis protein) family (44, 45). Y. enterocolitica
suppresses NF-kB activity, which in turn may affect ex-
pression of the genes that are necessary for cell survival.
This leads to domination of death-inducing pathways and
rapid apoptosis. This concept exactly fits to our previous
finding that Yersinia triggers apoptosis at a level upstream or
apart from the actual core apoptotic program (caspase activ-
ities) activated by death-inducing pathways (19). Further-
more, this mechanism explains why Y. enterocolitica triggers
apoptosis not only in macrophages, but also in epithelial
HeLa cells, provided that the appropriate death signal
(TNF-a in our experiments) is present. Interestingly, LPS
alone appears to be sufficient to signal the macrophage to
undergo apoptosis if activation of NF-kB is blocked by the
proteasome inhibitor MG-132. Cell death under these
conditions is not mediated by traces of TNF-a secreted by
the macrophage, since increasing amounts of TNF-a–neu-
tralizing antibodies added to the medium did not reduce
the rate of apoptosis (data not shown). This finding con-
firms that even during treatment with LPS, activation of
NF-kB is indispensable for cell survival.
The signaling pathways that induce programmed cell
death under conditions where NF-kB is inhibited are less
clear. Several lines of evidence indicate that MAPK mod-
ules are involved in the activation of apoptosis-inducing
pathways (46–50). The MAPK and NF-kB signaling sys-
tems represent two distinct but interactive signal transduc-
tion pathways (39, 51) and it may be possible that apoptosis
by Yersinia requires inhibition of NF-kB, as well as activa-
tion of MAPK cascades. Indeed, we found that Yersinia in-
fection initially activates the macrophage MAPK pathways
p38, ERK, and JNK (14). Using drugs that are presently
available and selectively block MAPK activities (SB203580,
PD098059), we analyzed the role of p38 and ERK in Yer-
sinia–macrophage interaction. Our experiments showed
that these drugs did not prevent cell death mediated by
wild-type Yersinia, which indicates that p38 and ERK are
at least not crucially implicated in Yersinia-induced apopto-
sis. On the other hand, these two compounds cumulatively
blocked the J774A.1 cell TNF-a production induced by
virulence plasmid–cured yersiniae without interfering with
activation of NF-kB. This proves that besides NF-kB, the
p38 and ERK MAPK pathways are also involved in
J774A.1 cell TNF-a production. Indeed, MAPK as well as
NF-kB signaling pathways play an important role in the
regulation of the macrophage TNF-a production, either at
the transcriptional (NF-kB, ERK, JNK) and/or posttran-
scriptional level (p38, JNK) (15–18, 52, 53). Activities of
these pathways contribute to TNF-a production rather ad-
ditively than competitively, since maximal activation of the
TNF promotor requires at least two cis-acting regulatory
elements, such as NF-kB and c-Jun (52). In agreement
with these findings, our results postulate that Y. enterocolitica
blocks the macrophage TNF-a production in a bimodal
manner, by inhibiting both the MAPK as well as the NF-
kB signaling pathways. The simultaneous affection of the
two signal transduction systems implies that Yersinia medi-
ates blockage of common upstream activators, such as the
signaling cascades of the Ras superfamily of small G pro-
teins, namely Cdc42, Rac-1, and Rho, which are impli-
cated in activation of NF-kB (54), as well as of MAPK
modules (55). Studies addressing this question are presently
underway.
In summary, our study provides new insights into the
mechanisms by which Y. enterocolitica subverts eukaryotic
cells and modulates the immune response of the host. Y.
enterocolitica interferes with the activation of transcription
factor NF-kB in eukaryotic cells. This strategy serves to
suppress the TNF-a production of macrophages and con-
tributes to trigger macrophage cell death by apoptosis. Epi-
thelial HeLa cells undergo apoptosis upon Yersinia infection
only when the cytokine TNF-a is present simultaneously.
Since yersiniae block the TNF-a secretion in vivo, this
may indicate a strategy of Yersinia to focus apoptosis selec-
tively towards macrophages, whereas nonphagocytic cells
escape programmed cell death due to Yersinia infection.
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